The challenge of predicting and preventing sudden cardiac death immediately after myocardial infarction

Circulation

Volumn 120, Issue 3, 2009, Pages 185-187

  Estes, N A Mark ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmia; Editorials; Myocardial infarction; Sudden death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AUTOMATED EXTERNAL DEFIBRILLATOR; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL TRIAL; EDITORIAL; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE;

DEATH, SUDDEN, CARDIAC; HUMANS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TIME FACTORS;

EID: 67651100459     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.879924     Document Type: Editorial

References (18)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2006;114:e385-e484.
2. Ottervanger JP, Ramdat Misier AR, Dambrink JH, de Boer MJ, Hoorntje JC, Gosselink AT, Suryapranata H, Reiffers S, van't Hof AW. Mortality in patients with left ventricular ejection fraction-30% after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol. 2007;100:793-797.
3. Hohnloser SH, Gersh BJ. Changing late prognosis of acute myocardial infarction: impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator. Circulation. 2003;107:941-946.
4. Solomon SD, Zelenkofske S, McMurray JJ. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352:2581-2588.
5. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Siscovick D, Stevenson WG, Zipes DP. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008;118:1497-1518.
6. Owens DK, Sanders GD, Heidenreich PD, McDonald K, Hlatky M. Effect of risk stratification on cost effectiveness of the implantable cardioverter defibrillator. Am Heart J. 2002;144:440-448.
7. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335: 1933-1940.
8. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
9. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, for the MUSTT Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial (MUSTT). N Engl J Med. 1999;341:1882-1890.
10. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
11. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ. Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction. DINAMIT Investigators. N Engl J Med. 2004;351:2481-2488.
12. Steinbeck G. A randomized study of defibrillator implantation early after myocardial infarction in high-risk patients on optimal medical therapy. Paper presented at: American College of Cardiology 2009 Scientific Sessions; March 31, 2009; Orlando, Fla.
13. Bardy GH, Lee KL, Mark DB, Poole JE, Toff WD, Tonkin AM, Smith W, Dorian P, Packer DL, White RD, Longstreth WT Jr, Anderson J, Johnson G, Bischoff E, Yallop JJ, McNulty S, Ray LD, Clapp-Channing NE, Rosenberg Y, Schron EB, HAT Investigators. Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med. 2008;358: 1793-1804.
14. Uther JB, Richards JB, Dennis AR, Ross DL. The prognostic significance of programmed ventricular stimulation after myocardial infarction. Circulation. 1987;75:1161-1165.
15. Denniss AR, Richards DA, Cody DV, Russell PA, Young AA, Cooper MJ, Ross DL, Uther JB. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation. 1986;74:731-745.
16. BhandarhiI A, Hong R, Kotelski A, McIntosh N, Au P, Sankoorikal A, Rahimtolla SH. Prognostic significance of programmed ventricular stimulation in survivors of acute myocardial. infarction. Br Heart J. 1989;61: 410-416.
17. Raviele A, Bongiorni MG, Brignole M, Cappato R, Capucci A, Gaita Gulizia M, Mangiameli S, Montenero AS, Pedretti RF, Uriarte JA, Sermasi S, Nisam S, BEST-ICD Trial Investigators. Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment: the BEtablocker STrategy plus ICD trial. Europace. 2005;7:327-337.
18. Zaman S, Sivagangabalan G, Narayan A, Thiagalingam A, Ross DL, Kovoor P. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circulation. 2009;120:194-200.